Rebates are shrinking, list prices are dropping and PBM contracts are quietly changing to keep up. Host Monica Gindhart unpacks how regulation is pushing manufacturers away from the high list price, high rebate model, what rebate credit clauses mean for your groups’ guarantees, and why lowest net cost, not the biggest rebate, should drive your next contract decision. No fluff — just what you need to know this month.

GLP-1 spend is climbing, approved uses are multiplying, and direct-to-consumer cash pricing is creating new pressures outside the pharmacy benefit. Host Brian Shonat unpacks why GLP-1 coverage decisions are getting more complicated for employers, why a blanket yes or no may not fit every group, and what to review before 1/1 renewals. Five minutes, no fluff — just what you need to know this month.

Rx spend is quietly one of the biggest variables in a group's move from fully insured to self-funded — and one of the easiest things to leave unmanaged once they get there.
Host Lad Williamson unpacks why carrier formularies and PBM contracts don't manage themselves, why pharmacy now regularly exceeds 30% of total plan spend, and the two questions every broker should be asking their groups before 1/1 renewals.
Five minutes, no fluff — just what you need to know this month.